Brian Lenz
2013 - ADMA Biologics
In 2013, Brian Lenz earned a total compensation of $343.9K as Chief Financial Officer at ADMA Biologics, a 51% decrease compared to previous year.
Compensation breakdown
| Bonus | $79,568 |
|---|---|
| Salary | $264,334 |
| Total | $343,902 |
Lenz received $264.3K in salary, accounting for 77% of the total pay in 2013.
Lenz also received $79.6K in bonus.
Rankings
In 2013, Brian Lenz's compensation ranked 10,480th out of 12,286 executives tracked by ExecPay. In other words, Lenz earned more than 14.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 10,480 out of 12,286 | 15th |
Division Manufacturing | 3,907 out of 4,612 | 15th |
Major group Chemicals And Allied Products | 1,241 out of 1,462 | 15th |
Industry group Drugs | 978 out of 1,156 | 15th |
Industry Biological Products, Except Diagnostic Substances | 160 out of 196 | 18th |
Source: SEC filing on April 29, 2014.
Lenz's colleagues
We found two more compensation records of executives who worked with Brian Lenz at ADMA Biologics in 2013.
News
ADMA Biologics CEO Adam Grossman's 2023 pay jumps 128% to $6M
April 15, 2024
ADMA Biologics CEO Adam Grossman's 2022 pay falls 39% to $2.6M
April 13, 2023
ADMA Biologics CEO Adam Grossman's 2021 pay jumps 122% to $4.4M
April 28, 2022
ADMA Biologics CEO Adam Grossman's 2020 pay rises 15% to $2M
April 7, 2021
ADMA Biologics CEO Adam Grossman's 2019 pay rises 10% to $1.7M
April 29, 2020
ADMA Biologics CEO Adam Grossman's 2018 pay falls 42% to $1.6M
April 24, 2019